Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis-Reference-Cited by-同舟云学术

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis

Published:2020-01-09 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sbidian Emilie¹²³,Chaimani Anna⁴⁵,Garcia-Doval Ignacio⁶,Doney Liz⁷,Dressler Corinna⁸,Hua Camille¹,Hughes Carolyn⁹,Naldi Luigi¹⁰,Afach Sivem²,Le Cleach Laurence¹²

Affiliation:

1. Department of Dermatology; Hôpital Henri Mondor; Créteil France

2. Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) - EA 7379; Université Paris Est Créteil (UPEC); Créteil France

3. Clinical Investigation Centre; Hôpital Henri Mondor; Créteil France

4. Université de Paris, Centre of Research in Epidemiology and Statistics (CRESS), INSERM, F-75004; Paris France

5. Cochrane France; Paris France

6. Department of Dermatology; Complexo Hospitalario Universitario de Vigo; Vigo Spain

7. Centre of Evidence Based Dermatology; Cochrane Skin Group, The University of Nottingham; Nottingham UK

8. Division of Evidence Based Medicine, Department of Dermatology, Venerology and Allergology; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Berlin Germany

9. c/o Cochrane Skin Group; The University of Nottingham; Nottingham UK

10. Centro Studi GISED (Italian Group for Epidemiologic Research in Dermatology) - FROM (Research Foundation of Ospedale Maggiore Bergamo); Padiglione Mazzoleni - Presidio Ospedaliero Matteo Rota; Bergamo Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011535.pub3/epdf/full

Reference858 articles.

1. Serum concentrations of interleukin-2 and tumour necrosis factor-alpha under cyclosporine versus acitretin treatment in plaque-type psoriasis;Akcali;Journal of International Medical Research,2014

2. Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of plaque-type psoriasis;Al-Hamamy;International Journal of Dermatology,2014

3. Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: efficacy and safety results from a Phase II/III randomized controlled study;Asahina;Journal of Dermatology,2010

4. Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: a randomized, double-blind, phase 3 study;Asahina;Journal of Dermatology,2016

5. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study;Asawanonda;Journal of the American Academy of Dermatology,2006

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ixekizumab trough concentrations in psoriasis: Paving the way towards personalised therapy: A cohort study;JEADV Clinical Practice;2024-07-04

2. Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data;Dermatology and Therapy;2024-05-24

3. Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group;International Journal of Dermatology;2024-05-12

4. Matching Drug Prices to Their Clinical Benefit—The Final Frontier?;JAMA Dermatology;2024-04-01

5. New Topical Therapy for Moderate Psoriasis: An Open-Label, Pilot Study;International Journal of Pharmaceutical And Phytopharmacological Research;2024